Innate and adaptive immune responses subsequent to ischemia-reperfusion injury in the kidney

Progres en Urologie

Volumn 24, Issue SUPPL.1, 2014, Pages

  Denecke, C ^a,b   Tullius, S G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adaptive immune response; Innate immune response; Reperfusion injury; T cells; Toll like receptors

Indexed keywords

ADAPTIVE IMMUNITY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; KIDNEY; KIDNEY TRANSPLANTATION; REPERFUSION INJURY; VASCULARIZATION;

ADAPTIVE IMMUNITY; HUMANS; IMMUNITY, INNATE; KIDNEY; KIDNEY TRANSPLANTATION; REPERFUSION INJURY;

EID: 84902463496     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1166-7087(14)70058-2     Document Type: Article

References (87)

1. Paterson H.M., Murphy T.J., Purcell E.J., Shelley O., Kriynovich S.J., Lien E., et al. Injury primes the innate immune system for enhanced toll-like receptor reactivity. J Immunol 2003, 171:1473.
2. Tullius S.G., Reutzel-Selke A., Egermann F., Nieminen-Kelhä M., Jonas S., Bechstein W.O., et al. Contribution of prolonged ischemia and donor age to chronic renal allograft dysfunction. J Am Soc Nephrol 2000, 11:1317.
3. Matzinger P. The danger model: A renewed sense of self. Science 2002, 296:301.
4. Rosenberger P., Schwab J.M., Mirakaj V., Masekowsky E., Mager A., Morote-Garcia J.C., et al. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol 2009, 10:195-202.
5. Eltzschig H.K., Collard C.D. Vascular ischaemia and reperfusion injury. Br Med Bull 2004, 70:71-86.
6. Hidalgo A., Chang J., Jang J.E., Peired A.J., Chiang E.Y., Frenette P.S. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med 2009, 15:384-391.
7. Thurman J.M., Ljubanovic D., Royer P.A., Kraus D.M., Molina H., Barry N.P., et al. Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. J Clin Invest 2006, 116:357-368.
8. Thurman J.M., Lenderink A.M., Royer P.A., Coleman K.E., Zhou J., Lambris J.D., et al. C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ischemia/reperfusion. J Immunol 2007, 178:1819-1828.
9. Kahles T., Brandes R.P. NADPH oxidases as therapeutic targets in ischemic stroke. Cell Mol Life Sci 2012, 69(14):2345-2363. Jul; Epub 2012 May 23 Review.
10. Land W., Schneeberger H., Schleibner S., Illner W.D., Abendroth D., Rutili G., et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994, 57:211.
11. Hotchkiss R.S., Strasser A., McDunn J.E., Swanson P.E., et al. Cell death. N. Engl. J. Med 2009, 361:1570-1583.
12. Chekeni F.B., Elliott M.R., Sandilos J.K., Walk S.F., Kinchen J.M., Lazarowski E.R., et al. Pannexin 1 channels mediate 'find-me'signal release and membrane permeability during apoptosis. Nature 2010, 467:863-867.
13. Awad A.S., Rouse M., Huang L., Vergis A.L., Reutershan J., Cathro H.P., et al. Okusa Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int 2009, 75(7):689-698. April.
14. Kelly K.J., Williams W.W., Colvin R.B., Meehan S.M., Springer T.A., Gutierrez-Ramos J.C., et al. Intercellular adhesion molecule-1- deficient mice are protected against ischemic renal injury. J Clin Invest 1996, 97:1056-1063.
15. Li L., Huang L., Sung S.S., Vergis A.L., Rosin D.L., Rose C.E., et al. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 2008, 74:1526-1537.
16. Day Y.J., Huang L., Ye H., Li L., Linden J., Okusa M.D., et al. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Renal Physiol 2005, 288:F722-F731.
17. Furuichi K., Wada T., Iwata Y., Kitagawa K., Kobayashi K., Hashimoto H., et al. CCR2 Signaling Contributes to Ischemia-Reperfusion Injury in Kidney. J Am Soc Nephrol 2003, 14(10):2503-2515.
18. Jo S.K., Sung S.A., Cho W.Y., Go K.J., Kim H.K. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 2006, 21(5):1231-1239.
19. Oh D.J., Dursun B., He Z., Lu L., Hoke T.S., Ljubanovic D., et al. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Renal Physiol 2008, 294(1):F264-F271.
20. Moser M., Nieswandt B., Ussar S., Pozgajova M., Fässler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 2008, 14:325-330.
21. de Vries B., Walter S.J., Peutz-Kootstra C.J., Wolfs T.G., van Heurn L.W., Buurman W.A., et al. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemiareperfusion injury. Am J Pathol 2004, 165:1677-1688.
22. Pratt J.R., Basheer S.A., Sacks S.H. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002, 8:582-587.
23. Fearon D.T., Carroll M.C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 2000, 18:393-422.
24. Hawlisch H., Wills-Karp M., Karp C.L., Köhl J. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol Immunol 2004, 41:123-131.
25. Heeger P.S., Lalli P.N., Lin F., Valujskikh A., Liu J., Muqim N., et al. Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 2005, 201:1523-1530.
26. Zhang Z.X., Wang S., Huang X., Min W.P., Sun H., Liu W., Garcia B., et al. NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J Immunol 2008, 181:7489-7498.
27. Kim H.J., Lee J.S., Kim J.D., Cha H.J., Kim A., Lee S.K., et al. Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation. Proc Natl Acad Sci USA. 2012, 109(1):E13-E22. Jan 3.
28. Martín-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for TH1 priming. Nat Immunol 2004, 5:1260.
29. Raulet D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 2004, 5:996.
30. Piccioli D., Sbrana S., Melandri E., Vallante N.M. Contactdependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med 2002, 195:335-341.
31. Zijlstra M., Auchincloss H., Loring J.M., Chase C.M., Russel P.S., Jaenisch R. Skin graft rejection by beta 2-microglobulin-defi- cient mice. J Exp Med 1992, 175:885-893.
32. Zhou T., Sun G.Z., Zhang M.J., Chen J.L., Zhang D.Q., Hu Q.S., et al. Role of adhesion molecules and dendritic cells in rat hepatic/renal ischemia-reperfusion injury and anti-adhesive intervention with anti-P-selectin lectin-EGF domain monoclonal antibody. World J Gastroenterol 2005, 11:1005-1010.
33. Dong X., Swaminathan S., Bachman L.A., Croatt A.J., Nath K.A., Griffin M.D. Antigen presentation by dendritic cells in renal lymph nodes is linked to systemic and local injury to the kidney. Kidney Int 2005, 68:1096-1108.
34. Penfield J.G., Dawidson I.A., Ar'Rajab A., Kielar M.A., Jeyarajah D.R., Lu C.Y. Syngeneic renal transplantation increases the number of renal dendritic cells in the rat. Transpl Immunol 1999, 7:197-200.
35. Dong X., Swaminathan S., Bachman L.A., Croatt A.J., Nath K.A., Griffin M.D. Resident dendritic cells are the predominant TNFsecreting cell in early renal ischemia-reperfusion injury. Kidney Int 2007, 71:619-628.
36. Land W.G. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 2005, 79:505.
37. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11(5):373-384. May.
38. Tsung A., Hoffman R.A., Izuishi K., Critcholow N.D., Nakao A., Chan M.H., et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005, 175:7661-7668.
39. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
40. El Shikh M.E., El Sayed R.M., Wu Y., Szakal A.K., Tew J.G. TLR4 on follicular dendritic cells: An activation pathway that promotes accessory activity. J Immunol 2007, 179:4444.
41. Shen X.-D., Ke B., Zhai Y., Gao F., Busuttil R.W., Cheng G., et al. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Trans 2005, 5:1793.
42. Zhai Y., Shen X.D., O'Connell R., Gao F., Lassman C., Busuttil R.W., et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004, 173:7115-7119.
43. Shishido T., Nozaki N., Yamaguchi S., Shibata Y., Nitobe J., Miyamoto T., et al. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 2003, 108:2905.
44. Kaczorowski D.J., Nakao A., Vallabhaneni R., Mollen K.P., Sugimoto R., Kohmoto J., et al. Mechanisms of toll-like receptor 4 (TLR4)- mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation 2009, 87:1455.
45. Wu H., Cheng G., Wyburn K.R., Yin J., Bertolino P., Eris J.M., et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 2007, 117:2847-2859.
46. Leemans J.C., Stokman G., Claessen N., Rouschop K.M., Teske G.J., Kirschning C.J., et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest 2005, 115:2894-2903.
47. Kruger B., Krick S., Dhillon N., Lerner S.M., Ames S., Bromberg J.S., et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl. Acad. Sci. USA 2009, 106:3390-3395.
48. Wu H., Noordmans G.A., O'Brien M.R., Ma J., Zhao C.Y., Zhang G.Y., et al. Absence of MyD88 signaling induces donor-specific kidney allograft tolerance. J Am Soc Nephrol 2012, 23(10):1701-1716. Oct; Epub 2012 Aug 9.
49. Chen L., Wang T., Zhou P., Ma L., Yin D., Shen J., et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006, 6:2282.
50. Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4_CD25_ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033.
51. Satpute S.R., Park J.M., Jang H.R., Agreda P., Liu M., Gandolfo M.T., et al. The role for T cell repertoire/antigen-specific interactions in experimental kidney ischemia reperfusion injury. J. Immunol 2009, 183:984-992.
52. Burne-Taney M.J., Ascon D.B., Daniels F., Racusen L., Baldwin W., Rabb H. J. Immunol 2003, 171:3210-3215. B cell deficiency confers protection from renal ischemia reperfusion injury.
53. Yokota N., Daniels F., Crosson J., Rabb H., et al. Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation 2002, 74:759-763.
54. Huang Y., Rabb H., Womer K.L. Ischemia-reperfusion and immediate T cell responses. Cell. Immunol 2007, 248:4-11.
55. Takada M., Chandraker A., Nadeau K.C., Sayegh M.H., Tilney N.L. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997, 100:1199-1203.
56. De Greef K.E., Ysebaert D.K., Dauwe S., Persy V., Vercauteren S.R., Mey D., et al. Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int 2001, 60:1415-1427.
57. Ishikawa M., Vowinkel T., Stokes K.Y., Arumugam T.V., Yilmaz G., Nanda A., et al. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation 2005, 111:1690-1696.
58. Boros P., Bromberg J.S. New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant 2006, 6:652-658.
59. Burne-Taney M.J., Yokota N., Rabb H. Persistent renal and extrarenal immune changes after severe ischemic injury. Kidney Int 2005, 67:1002-1009.
60. Day Y.J., Huang L., Ye H., Li L., Linden J., Okusa M.D., et al. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol 2006, 176:3108-3114.
61. Burne M.J., Daniels F., El Ghandour A., Mauiyyedi S., Colvin R.B., O'Donnell M.P., et al. Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001, 108:1283-1290.
62. Garcia-Criado F.J., Lozano-Sanchez F., Fernandez-Regalado J., Valdunciel-Garcia J.J., Parreno-Manchado F., Silva-Benito I., et al. Possible tacrolimus action mechanisms in its protector effects on ischemia-reperfusion injury. Transplantation 1998, 66:942-943.
63. Ysebaert D.K., De Greef K.E., Vercauteren S.R., Verhulst A., Kockx M., Verpooten G.A., et al. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury. Kidney Int 2003, 64:864-873.
64. Dragun D., Bohler T., Nieminen-Kelha M., Waiser J., Schneider W., Haller H., et al. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury. Kidney Int 2004, 65:1076-1083.
65. Liesz A., Suri-Payer E., Veltkamp C., Doerr H., Sommer C., Rivest S., et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med 2009, 15:192-199.
66. Marques V.P., Gonçalves G.M., Feitoza C.Q., Cenedeze M.A., Fernandes Bertocchi A.P., Damiao M.J., et al. Influence of TH1/TH2 switched immune response on renal ischemia-reperfusion injury. Nephron Exp Nephrol 2006, 104(1):e48-e56.
67. Loverre A., Divella C., Castellano G., Tataranni T., Zaza G., Rossini M., et al. T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function. Transpl Int 2011, 24(3):233-242. Mar.
68. Nussler N.C., Muller A.R., Weidenbach H., Vergopoulos A., Platz K.P., Volk H.D., et al. IL-10 increases tissue injury after selective intestinal ischemia/reperfusion. Ann Surg 2003, 238:49-58.
69. El-Sawy T., Miura M., Fairchild R. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innatemediated nflammation and graft necrosis. Am J Pathol 2004, 165:147-157.
70. Shichita T., Sugiyama Y., Ooboshi H., Sugimori H., Nakagawa R., Takada I., et al. Pivotal role of cerebral interleukin-17-producing gd T cells in the delayed phase of ischemic brain injury. Nat. Med 2009, 15:946-950.
71. Petrowsky H., McCormack L., Trujillo M., Selzner M., Jochum W., Clavien P.A., et al. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann. Surg 2006, 244:921-928. discussion 928-30.
72. Azoulay D., Del Gaudio M., Andreani P., Ichai P., Sebag M., Adam R., et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang. Ann. Surg 2005, 242:133-139.
73. Wever K.E., Menting T.P., Rovers M., van der Vliet J.A., Rongen G.A., Masereeuw R., et al. Ischemic Preconditioning in the Animal Kidney, a Systematic Review and Meta-Analysis. PLoS One 2012, 7(2). e63229.
74. Lang J.D., Teng X., Chumley P., Crawford J.H., Isbell T.S., Chacko B.K., et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J. Clin. Invest 2007, 117:2583-2591.
75. Kelpke S.S., Chen B., Bradley K.M., Teng X., Chumley P., Brandon A., et al. Sodium nitrite protects against kidney injury induced by brain death and improves post-transplant function. Kidney Int 2012, 82(3):304-313. Aug; doi: 10.1038/ki.2012.116. Epub 2012 Apr 25.
76. Huang S., Apasov S., Koshiba M., Sitkovsky M., et al. Role of A2a extracellular adenosine receptormediated signaling in adenosine- mediated inhibition of T-cell activation and expansion. Blood 1997, 90(4):1600-1610.
77. Li L., Huang L., Ye H., Song S.P., Bajwa A., Lee S.J., et al. Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury. J Clin Invest 2012, 122(11):3931-3942.
78. Day Y.J., Li Y., Rieger J.M., Ramos S.I., Okusa M.D., Linden J., et al. A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury. J Immunol 2005, 174(8):5040-5046.
79. Sevigny C.P., Li L., Awad A.S., Huang L., McDuffie M., Linden J., et al. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J Immunol 2007, 178(7):4240-4249.
80. Fenhammar J., Rundgren M., Forestier J., Kalman S., Eriksson S., Frithiof R. Toll-like receptor 4 inhibitor TAK-242 attenuates acute kidney injury in endotoxemic sheep. Anesthesiology 2011, 114:1130-1137.
81. Jiang J., Arp J., Kubelik D., Zassoko R., Liu W., Wise Y., et al. Induction of indefinite cardiac allograft survival correlates with toll-like receptor 2 and 4 downregulation after serine protease inhibitor-1 (Serp-1) treatment. Transplantation 2007, 84:1158.
82. Rice T.W., Wheeler A.P., Bernard G.R., Vincent J.L., Angus D.C., Aikawa N., et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit. Care Med 2010, 38:1685-1694.
83. Imamura R., Moriyama T., Isaka Y., Namba Y., Ichimaru N., Takahara S., et al. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor- 1alpha. Transplantation 2007, 83:1371.
84. Imamura R., Isaka Y., Ichimaru N., Takahara S., Okuyama A. Carbamylated erythropoietin protects the kidneys from ischemia-reperfusion injury without stimulating erythropoiesis. Biochem Biophys Res Commun 2007, 353:786.
85. Tullius S.G., Nieminen-Kelha'M, Buelow R., Reutzel-Selke A., Martins P.N., Pratschke J., et al. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 2002, 74:591.
86. Kotsch K., Francuski M., Pascher A., Klemz R., Seifert M., Mittler J., et al. Improved long-term graft survival after HO-1 induction in brain-dead donors. Am J Transplant 2006, 6:477.
87. Thakar C.V., Zahedi K., Revelo M.P., Wang Z., Burnham C.E., Barone S., et al. Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J. Clin Invest 2005, 115:3451-3459.